Authors: Cohen, D Sela, T Slepon, R Yavzori, M Ambar, R Orr, N Robin, G Shpielberg, O Eldad, A Green, M

Citation: D. Cohen et al., Prospective cohort studies of shigellosis during military field training, EUR J CL M, 20(2), 2001, pp. 123-126

Authors: Robin, G Fraser, D Orr, N Sela, T Siepon, R Ambar, R Dagan, R Le Blancq, S Deckelbaum, RJ Cohen, D

Citation: G. Robin et al., Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination, AM J EPIDEM, 153(2), 2001, pp. 194-201

Authors: Cohen, D Orr, N Haim, M Ashkenazi, S Robin, G Green, MS Ephros, M Sela, T Slepon, R Ashkenazi, I Taylor, DN Svennerholm, AM Eldad, A Shemer, J

Citation: D. Cohen et al., Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli cholera toxin B subunit vaccine in Israeli youngadults, INFEC IMMUN, 68(8), 2000, pp. 4492-4497

Authors: Almog, R Low, M Cohen, D Robin, G Ashkenazi, S Bercovier, H Gdalevich, M Samuels, Y Ashkenazi, I Shemer, J Eldad, A Green, MS

Citation: R. Almog et al., Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991, INFECTION, 27(3), 1999, pp. 212-217

Authors: Robin, G Keisari, Y Slepon, R Ashkenazi, S Cohen, D

Citation: G. Robin et al., Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines, VACCINE, 17(23-24), 1999, pp. 3109-3115

Authors: Coster, TS Hoge, CW Van de Verg, LL Hartman, AB Oaks, EV Venkatesan, MM Cohen, D Robin, G Fontaine-Thompson, A Sansonetti, PJ Hale, TL

Citation: Ts. Coster et al., Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602, INFEC IMMUN, 67(7), 1999, pp. 3437-3443